Skip to content

Debt Repayments at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$500M
Labcorp Holdings logo
Labcorp HoldingsLH
$0-100%
Quest Diagnostics logo
Quest DiagnosticsDGX
$1M-99.8%
GeneDx Holdings logo
GeneDx HoldingsWGS
$2M
Agilent Technologies logo
Agilent TechnologiesA
$1M
Revvity logo
RevvityRVTY
$0+100%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfNotesPayable.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s debt repayments?
Fulgent Genetics, Inc. (FLGT) reported debt repayments of $476K in Q1 2026.
How has Fulgent Genetics, Inc.'s debt repayments changed year-over-year?
Fulgent Genetics, Inc.'s debt repayments increased by 1.3% year-over-year, from $470K to $476K.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.